Literature DB >> 12889217

Assessment of lung involvement.

M Matucci-Cerinic1, S D'Angelo, C P Denton, P Vlachoyiannopoulos, R Silver.   

Abstract

The aim of the subcommittee was to identify a core set of feasible variables reflecting the occurrence of interstitial and/or vascular lung disease. After extensive review of published studies and critical assessment of candidate variables, the subcommittee identified the minimal requirements to assess lung disease. Two core sets of variables are provided: the first concerns interstitial lung disease; the second pulmonary vascular disease.

Entities:  

Mesh:

Year:  2003        PMID: 12889217

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Authors:  Beth Wallace; Suzanne Kafaja; Daniel E Furst; Veronica J Berrocal; Peter A Merkel; James R Seibold; Maureen D Mayes; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2015-02-09       Impact factor: 7.580

Review 3.  Interstitial lung disease in systemic sclerosis.

Authors:  O Kaloudi; I Miniati; S Alari; M Matucci-Cerinic
Journal:  Intern Emerg Med       Date:  2007-12-17       Impact factor: 3.397

4.  Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients.

Authors:  Y Allanore; D Borderie; P Airo; S Guiducci; L Czirják; E L Nasonov; G Riemekasten; P Caramaschi; M Majdan; D Krasowska; E Friedl; H Lemarechal; L P Ananieva; T Nievskaya; O G Ekindjian; M Matucci-Cerinic; A Kahan
Journal:  Ann Rheum Dis       Date:  2006-06-01       Impact factor: 19.103

Review 5.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

6.  A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.

Authors:  B Rueda; C Simeon; R Hesselstrand; A Herrick; J Worthington; N Ortego-Centeno; G Riemekasten; V Fonollosa; M C Vonk; F H J van den Hoogen; J Sanchez-Román; M A Aguirre-Zamorano; R García-Portales; A Pros; M T Camps; M A Gonzalez-Gay; M F Gonzalez-Escribano; M J Coenen; N Lambert; J L Nelson; T R D J Radstake; J Martin
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

7.  Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.

Authors:  Thomas Hyphantis; Barbara Tomenson; Vassiliki Paika; Augoustina Almyroudi; Chrisavgi Pappa; Niki Tsifetaki; Paraskevi V Voulgari; Alexandros A Drosos; Nicholas Pavlidis; Francis Creed
Journal:  Qual Life Res       Date:  2009-08-22       Impact factor: 4.147

8.  The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study.

Authors:  Giovanni La Montagna; Antonio Sodano; Vittorio Capurro; Domenico Malesci; Gabriele Valentini
Journal:  Skeletal Radiol       Date:  2004-09-17       Impact factor: 2.199

9.  Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.

Authors:  Alberto Pignone; Angela Del Rosso; K Bridget Brosnihan; Federico Perfetto; Riccardo Livi; Ginevra Fiori; Serena Guiducci; Marina Cinelli; Veronica Rogai; Alessio Tempestini; Francesca Bartoli; Sergio Generini; Carlos M Ferrario; Marco Matucci Cerinic
Journal:  Ann Rheum Dis       Date:  2007-03-14       Impact factor: 19.103

10.  Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.

Authors:  L M Diaz-Gallo; P Gourh; J Broen; C Simeon; V Fonollosa; N Ortego-Centeno; S Agarwal; M C Vonk; M Coenen; G Riemekasten; N Hunzelmann; R Hesselstrand; F K Tan; J D Reveille; S Assassi; F J García-Hernandez; P Carreira; M T Camps; A Fernandez-Nebro; P Garcia de la Peña; T Nearney; D Hilda; M A González-Gay; P Airo; L Beretta; R Scorza; A Herrick; J Worthington; A Pros; I Gómez-Gracia; L Trapiella; G Espinosa; I Castellvi; T Witte; F de Keyser; M Vanthuyne; M D Mayes; T R D J Radstake; F C Arnett; J Martin; B Rueda
Journal:  Ann Rheum Dis       Date:  2010-12-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.